Header Logo
Last Name

Katerina Cermakova

TitlePostdoc Fellows and Associates
InstitutionBaylor College of Medicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Cermakova K, Hodges HC. Next-Generation Drugs and Probes for Chromatin Biology: From Targeted Protein Degradation to Phase Separation. Molecules. 2018 Aug 06; 23(8). PMID: 30082609.
      View in: PubMed
    2. Hodges HC, Stanton BZ, Cermakova K, Chang CY, Miller EL, Kirkland JG, Ku WL, Veverka V, Zhao K, Crabtree GR. Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers. Nat Struct Mol Biol. 2018 01; 25(1):61-72. PMID: 29323272.
      View in: PubMed
    3. Cermakova K, Weydert C, Christ F, De Rijck J, Debyser Z. Lessons Learned: HIV Points the Way Towards Precision Treatment of Mixed-Lineage Leukemia. Trends Pharmacol Sci. 2016 08; 37(8):660-671. PMID: 27290878.
      View in: PubMed
    4. El Ashkar S, De Rijck J, Demeulemeester J, Vets S, Madlala P, Cermakova K, Debyser Z, Gijsbers R. BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements. Mol Ther Nucleic Acids. 2014 Jul 29; 3:e179. PMID: 25072693.
      View in: PubMed
    5. Vinsova J, Cermakova K, Tomeckova A, Ceckova M, Jampilek J, Cermak P, Kunes J, Dolezal M, Staud F. Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles. Bioorg Med Chem. 2006 Sep 01; 14(17):5850-65. PMID: 16784871.
      View in: PubMed
    Cermakova's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description